All AbMole products are for research use only, cannot be used for human consumption.
Nebivolol (Bystolic) is a β1 receptor blocker with an IC50 of 4.5 µM. It has nitric oxide-potentiating vasodilatory effect used in treatment of hypertension. Nebivolol was compared with DETA-NO and S-nitroso-N-acetylpenicillamine (SNAP), two nitric oxide (NO) donor agents, and alpha-difluoromethylornithine (DFMO), a known inhibitor of ornithine decarboxylase (ODC). All four test agents inhibited RASMC proliferation in a concentration-dependent manner, with nebivolol being the most potent (IC (50) = 4.5 microM), whereas atenolol, another relatively selective beta (1)-blocker, was inactive.
| Cell Experiment | |
|---|---|
| Cell lines | Human coronary smooth muscle cells (haCSMCs) and endothelial cells (haECs) |
| Preparation method | Exposing cells to different concentrations of Nebivolol (10-7~10-5 M) for 1, 2, 4, 7 and 14 days. Using bromodeoxyuridine (BrdU) incorporation to analyze cell proliferation , and PI or annexin V staining to detect cell apoptosis . |
| Concentrations | Dissolved in 100% methanol and diluted with three volumes of growth medium to obtain a stock solution of 10-3 M, final concentration 10-7~10-5 M |
| Incubation time | 1, 2, 4, 7 and 14 days |
| Animal Experiment | |
|---|---|
| Animal models | Male Sprague Dawley rat myocardial infarction (MI) model |
| Formulation | Dissolved in DMSO and diluted in saline |
| Dosages | 2.0 mg/kg |
| Administration | Gastric gavage once daily |
| Molecular Weight | 441.9 |
| Formula | C22H25F2NO4.HCl |
| CAS Number | 152520-56-4 |
| Solubility (25°C) | DMSO 80 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] Sarah J Wang, et al. Nebivolol/valsartan combination for the treatment of hypertension: a review
[2] Nasima Olawi, et al. Nebivolol in the treatment of arterial hypertension
[3] Dawn Battise, et al. Nebivolol/Valsartan: A Novel Antihypertensive Fixed-Dose Combination Tablet
[4] Justin Fongemie, et al. A Review of Nebivolol Pharmacology and Clinical Evidence
| Related Adrenergic Receptor Products |
|---|
| Indoramin
Indoramin is a selective α1A-adrenoceptor antagonist. |
| Ro 363 hydrochloride
Ro 363 hydrochloride is a potent and highly selective β1-adrenoceptor agonist. Ro 363 hydrochloride is also an effective inotropic stimulant. Ro 363 hydrochloride is a cardiovascular modulator that reduces diastolic blood pressure and pronounces increases in myocardial contractility. |
| Phentolamine
Phentolamine is a potent, selective and orally active α1 adrenergic and α2 adrenergic receptor antagonist. |
| Dipivefrin
Dipivefrin is a potent adrenergic agonist. |
| HOKU-81
HOKU-81 (4-Hydroxytulobuterol) is one of the metabolites of Tulobuterol. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
